FDA’s Nonprescription Office Adds Executive Posts To Fulfill “Safety First”
This article was originally published in The Tan Sheet
Executive Summary
FDA's office with oversight of over-the-counter drugs is adding executive positions as part of the agency's "Safety First" initiative
You may also be interested in...
FDA Sheds Cumbersome Hiring Process To Beef Up Scientific Capabilities
FDA is launching a recruitment blitz to fill more than 1,300 staff positions following an Office of Personnel Management decision to give the agency direct-hire authority, which allows it to bypass certain Department of Health and Human Services rating and ranking procedures when assessing applicants
FDA “Safety First” Initiative, Agency’s Requests Draw Doubts From DeLauro
FDA is implementing the Safety First initiative to "ensure that significant post-market safety issues are our highest priority," according to acting Center for Drug Evaluation and Research Director Janet Woodcock
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC